Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | FORM 10-K | pfe-12312017x10kshell.htm | 10-K | 815944 |
| 2 | FORM OF ACKN CONSENT SUMMARY OF KEY TERMS FOR STOCK OPTION GRANTS, RSUS & TSRUS | pfe-exhibit104x1231201.htm | EX-10.4 | 91534 |
| 3 | PFE CONSOLIDATED SUPPLEMENTAL PENSION PLAN FOR U.S. AND PUERTO RICO EMPLOYEES | pfe-exhibit106x1231201.htm | EX-10.6 | 631206 |
| 4 | AMENDMENT NO 2 TO THE PFIZER SUPPLEMENTAL SAVINGS PLAN | pfe-exhibit109x1231201.htm | EX-10.9 | 16283 |
| 5 | FORM OF SPECIAL PERFORMANCE BASED INCENTIVE AWARD LETTER | pfe-exhibit1026x123120.htm | EX-10.26 | 11609 |
| 6 | FORM OF SPECIAL PERFORMANCE BASED INCENTIVE GRANT LETTER | pfe-exhibit1027x123120.htm | EX-10.27 | 12550 |
| 7 | COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES | pfe-exhibit12x12312017.htm | EX-12 | 88718 |
| 8 | 2017 FINANCIAL REPORT | pfe-exhibit13x12312017x10k.htm | EX-13 | 7287289 |
| 9 | SUBSIDIARIES OF THE COMPANY | pfe-exhibit21x12312017.htm | EX-21 | 258152 |
| 10 | CONSENT OF KPMG, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | pfe-exhibit23x12312017.htm | EX-23 | 8728 |
| 11 | CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER - 302 | pfe-exhibit311x1231201.htm | EX-31.1 | 9721 |
| 12 | CERTIFICATION BY THE CHIEF FINANCIAL OFFICER - 302 | pfe-exhibit312x1231201.htm | EX-31.2 | 9770 |
| 13 | CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER - 906 | pfe-exhibit321x1231201.htm | EX-32.1 | 6574 |
| 14 | CERTIFICATION BY THE CHIEF FINANCIAL OFFICER - 906 | pfe-exhibit322x1231201.htm | EX-32.2 | 6733 |
| 21 | adjdilutedepsnongaap2017.jpg | GRAPHIC | 9851 | |
| 22 | bluedot.jpg | GRAPHIC | 3325 | |
| 23 | bluedota01.jpg | GRAPHIC | 3325 | |
| 24 | countriesoutsideus500mrev.jpg | GRAPHIC | 17480 | |
| 25 | darkbluedot.jpg | GRAPHIC | 3178 | |
| 26 | ehgeorevs2015.jpg | GRAPHIC | 17179 | |
| 27 | ehgeorevs2016.jpg | GRAPHIC | 17224 | |
| 28 | ehgeorevs2017.jpg | GRAPHIC | 17220 | |
| 29 | ehprcntoftotal1bdirsls.jpg | GRAPHIC | 20136 | |
| 30 | ehrev2016v2015.jpg | GRAPHIC | 24013 | |
| 31 | ehrev2017v2016.jpg | GRAPHIC | 27656 | |
| 32 | franksignatureq42014a07.jpg | GRAPHIC | 15323 | |
| 33 | greendot.jpg | GRAPHIC | 2598 | |
| 34 | greendota01.jpg | GRAPHIC | 2598 | |
| 35 | iansignatureq42014a07.jpg | GRAPHIC | 13834 | |
| 36 | ihgeorevs2015.jpg | GRAPHIC | 15115 | |
| 37 | ihgeorevs2016.jpg | GRAPHIC | 15293 | |
| 38 | ihgeorevs2017.jpg | GRAPHIC | 15343 | |
| 39 | ihprcntoftotal1bdirprod.jpg | GRAPHIC | 24510 | |
| 40 | ihrev2016v2015.jpg | GRAPHIC | 26201 | |
| 41 | ihrev2017v2016.jpg | GRAPHIC | 23034 | |
| 42 | innovativehealthrgb.jpg | GRAPHIC | 129311 | |
| 43 | kpmgsignatureq42014a07.jpg | GRAPHIC | 2159 | |
| 44 | lorettasignatureq42014a07.jpg | GRAPHIC | 19069 | |
| 45 | netcashflow-operations2017.jpg | GRAPHIC | 9723 | |
| 46 | orangedot.jpg | GRAPHIC | 3159 | |
| 47 | orangedota01.jpg | GRAPHIC | 3159 | |
| 48 | overviewrev2017v2016.jpg | GRAPHIC | 28200 | |
| 49 | peergroupgraph2017.jpg | GRAPHIC | 52770 | |
| 50 | pehlogo.jpg | GRAPHIC | 33481 | |
| 51 | pfizercoverlogoa01.jpg | GRAPHIC | 95651 | |
| 52 | pfizerlogo.jpg | GRAPHIC | 26092 | |
| 53 | pfizerlogoexhibit1026.jpg | GRAPHIC | 95575 | |
| 54 | pfizerlogoexhibit1027.jpg | GRAPHIC | 95575 | |
| 55 | pfizerpipeline01301801.jpg | GRAPHIC | 49954 | |
| 56 | purpledot.jpg | GRAPHIC | 3060 | |
| 57 | purpledota01.jpg | GRAPHIC | 3060 | |
| 58 | reporteddilutedeps2017.jpg | GRAPHIC | 8147 | |
| 59 | researchdevexp201720162015.jpg | GRAPHIC | 19883 | |
| 60 | revenuesbynatlmrkt.jpg | GRAPHIC | 40929 | |
| 61 | revenuesbynatlmrktfor10k.jpg | GRAPHIC | 46234 | |
| 62 | revsbysegandgeogus-intnl.jpg | GRAPHIC | 52036 | |
| 63 | shell-countries500m.jpg | GRAPHIC | 20030 | |
| 64 | totalrevenue2017.jpg | GRAPHIC | 9939 | |
| 65 | totalrevsprcntmjrbiowhls2017.jpg | GRAPHIC | 20535 | |
| 66 | usrevsprcntmjrbiwhls.jpg | GRAPHIC | 20869 | |
| 67 | yellowdot.jpg | GRAPHIC | 2616 | |
| Complete submission text file | 0000078003-18-000027.txt | 43501143 |
Data Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 15 | XBRL INSTANCE DOCUMENT | pfe-20171231.xml | EX-101.INS | 11938049 |
| 16 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | pfe-20171231.xsd | EX-101.SCH | 203215 |
| 17 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | pfe-20171231_cal.xml | EX-101.CAL | 270336 |
| 18 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | pfe-20171231_def.xml | EX-101.DEF | 1359173 |
| 19 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | pfe-20171231_lab.xml | EX-101.LAB | 2264897 |
| 20 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | pfe-20171231_pre.xml | EX-101.PRE | 1714062 |
IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-03619 | Film No.: 18632386
SIC: 2834 Pharmaceutical Preparations
